Free Trial
NYSE:BHC

Bausch Health Cos (BHC) Stock Price, News & Analysis

Bausch Health Cos logo
$6.70 -0.01 (-0.07%)
As of 12:56 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Bausch Health Cos Stock (NYSE:BHC)

Key Stats

Today's Range
$6.66
$6.85
50-Day Range
$4.46
$7.11
52-Week Range
$3.96
$9.85
Volume
367,187 shs
Average Volume
2.60 million shs
Market Capitalization
$2.48 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.42
Consensus Rating
Reduce

Company Overview

Bausch Health Cos Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
61st Percentile Overall Score

BHC MarketRank™: 

Bausch Health Cos scored higher than 61% of companies evaluated by MarketBeat, and ranked 384th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Bausch Health Cos has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on no buy ratings, 6 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Bausch Health Cos has only been the subject of 1 research reports in the past 90 days.

  • Read more about Bausch Health Cos' stock forecast and price target.
  • Earnings Growth

    Earnings for Bausch Health Cos are expected to grow by 5.67% in the coming year, from $4.41 to $4.66 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bausch Health Cos is -61.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bausch Health Cos is -61.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Bausch Health Cos' valuation and earnings.
  • Percentage of Shares Shorted

    2.99% of the float of Bausch Health Cos has been sold short.
  • Short Interest Ratio / Days to Cover

    Bausch Health Cos has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bausch Health Cos has recently increased by 0.81%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Bausch Health Cos does not currently pay a dividend.

  • Dividend Growth

    Bausch Health Cos does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.99% of the float of Bausch Health Cos has been sold short.
  • Short Interest Ratio / Days to Cover

    Bausch Health Cos has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bausch Health Cos has recently increased by 0.81%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Bausch Health Cos has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Bausch Health Cos this week, compared to 4 articles on an average week.
  • Search Interest

    24 people have searched for BHC on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Bausch Health Cos to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bausch Health Cos insiders have bought more of their company's stock than they have sold. Specifically, they have bought $35,870,767.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 8.12% of the stock of Bausch Health Cos is held by insiders.

  • Percentage Held by Institutions

    78.65% of the stock of Bausch Health Cos is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Bausch Health Cos' insider trading history.
Receive BHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch Health Cos and its competitors with MarketBeat's FREE daily newsletter.

BHC Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Bausch Health Companies Inc. (BHC) - Yahoo Finance
Stocks in play: Bausch Health Companies
Bausch Health Companies Inc. (BHC.TO) - Yahoo Finance
BHC Bausch Health Companies Inc. - Seeking Alpha
See More Headlines

BHC Stock Analysis - Frequently Asked Questions

Bausch Health Cos' stock was trading at $8.06 on January 1st, 2025. Since then, BHC shares have decreased by 15.3% and is now trading at $6.8250.

Bausch Health Cos Inc. (NYSE:BHC) issued its earnings results on Wednesday, February, 19th. The company reported $1.21 EPS for the quarter, missing the consensus estimate of $1.65 by $0.44. The firm earned $2.56 billion during the quarter, compared to the consensus estimate of $2.51 billion. Bausch Health Cos had a negative trailing twelve-month return on equity of 540.45% and a negative net margin of 0.41%.
Read the conference call transcript
.

Top institutional investors of Bausch Health Cos include Range Financial Group LLC (0.04%) and Marotta Asset Management. Insiders that own company stock include John Paulson and Seana Carson.
View institutional ownership trends
.

Shares of BHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Cos investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Tesla (TSLA), Bristol Myers Squibb (BMY) and Gilead Sciences (GILD).

Company Calendar

Last Earnings
2/19/2025
Today
7/09/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - GENERIC DRG
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:BHC
CIK
885590
Employees
20,700
Year Founded
N/A

Price Target and Rating

High Price Target
$10.00
Low Price Target
$3.00
Potential Upside/Downside
+11.3%
Consensus Rating
Reduce
Rating Score (0-4)
1.86
Research Coverage
7 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
1.51
P/E Growth
N/A
Net Income
-$46 million
Pretax Margin
1.94%

Debt

Sales & Book Value

Annual Sales
$9.63 billion
Cash Flow
$7.49 per share
Price / Cash Flow
0.89
Book Value
($0.89) per share
Price / Book
-7.49

Miscellaneous

Free Float
340,032,000
Market Cap
$2.47 billion
Optionable
Optionable
Beta
0.41
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NYSE:BHC) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners